How large is the connected drug delivery devices market?

The market size of connected drug delivery devices in 2027 is calculated to be USD 13.26 billion.

What is the anticipated CAGR of the connected drug delivery devices industry?

Connected Drug Delivery Devices Market size stood at USD 11.2 billion in 2026 and is predicted to grow at a 21.85% CAGR from 2027 to 2036, reaching USD 80.81 billion by 2036.

How is the expansion of remote patient monitoring shaping demand for connected drug delivery devices?

Remote monitoring is increasing demand for connected devices that capture dosing behavior and transmit treatment data to clinicians. This improves adherence visibility and enables providers to manage chronic therapies more effectively outside traditional clinical settings.

Why is integration between digital platforms and drug delivery devices accelerating diabetes care adoption?

Integration with digital diabetes ecosystems is improving treatment coordination by linking insulin delivery with glucose tracking and adherence tools. This creates more complete care workflows, making connected devices more attractive for long-term diabetes management.

Why does Diabetes Management lead the connected drug delivery devices market?

Diabetes Management accounted for 32.4% of the market in 2026, driven by the routine need for insulin delivery, dose tracking, adherence monitoring, and continuous patient engagement.

Why are Integrated Devices the fastest-growing product type in the connected drug delivery devices market?

Integrated Devices are expanding fastest because they combine drug delivery and connectivity in one system, simplifying treatment while enabling consistent data transmission and easier integration into routine care workflows.

Why does North America hold the largest share of the connected drug delivery devices market?

North America leads the market through strong adoption of digital healthcare, established reimbursement systems, and widespread integration of connected therapies into chronic disease management workflows.

What is driving rapid growth in the connected drug delivery devices market across Asia Pacific?

Asia Pacific is forecast to grow at a 24.97% CAGR as digital health adoption expands and healthcare providers increasingly deploy connected solutions for medication tracking and remote patient management.

Who holds a significant market share in the connected drug delivery devices landscape?

Key players in the connected drug delivery devices market include Medtronic plc (Ireland), Teva Pharmaceutical Industries Ltd. (Israel), Koninklijke Philips N.V. (Netherlands), Ypsomed Holding AG (Switzerland), Biocorp Production S.A. (France), Propeller Health (United States), Adherium Limited (New Zealand), Amiko Digital Health Ltd. (Switzerland), Phillips-Medisize LLC (United States), Cohero Health Inc. (United States).

Healthcare & Medical Devices - Custom Market Research Reports

The Healthcare & Medical Devices Research Team

This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.

Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.

HC Reports in this section are prepared and reviewed by the Healthcare & Medical Devices research team.

Secondary source	Official website
World Health Organization (WHO)	who.int ↗
U.S. Food & Drug Administration (FDA)	fda.gov ↗
European Medicines Agency (EMA)	ema.europa.eu ↗
Centers for Disease Control and Prevention (CDC)	cdc.gov ↗
National Institutes of Health (NIH)	nih.gov ↗
National Center for Biotechnology Information (NCBI)	ncbi.nlm.nih.gov ↗
PubMed	pubmed.ncbi.nlm.nih.gov ↗
ClinicalTrials.gov	clinicaltrials.gov ↗
International Organization for Standardization (ISO)	iso.org ↗
ASTM International	astm.org ↗
Advanced Medical Technology Association (AdvaMed)	advamed.org ↗
Medical Device Innovation Consortium (MDIC)	mdic.org ↗
Biotechnology Innovation Organization (BIO)	bio.org ↗
Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA)	ifpma.org ↗
U.S. Pharmacopeia (USP)	usp.org ↗
European Directorate for the Quality of Medicines & HealthCare (EDQM)	edqm.eu ↗
World Organisation for Animal Health (WOAH)	woah.org ↗
American Hospital Association (AHA)	aha.org ↗
OECD Health	oecd.org/health ↗
World Bank Data	data.worldbank.org ↗

Secondary source

Official website

World Health Organization (WHO)

who.int ↗

U.S. Food & Drug Administration (FDA)

fda.gov ↗

European Medicines Agency (EMA)

ema.europa.eu ↗

Centers for Disease Control and Prevention (CDC)

cdc.gov ↗

National Institutes of Health (NIH)

nih.gov ↗